April seven, 2020 — The use of the anti-malarial drug chloroquine to handle COVID-19 patients has been halted at a number of Swedish hospitals owing to described side consequences these kinds of as cramps and loss of peripheral eyesight.

Sahlgrenska College Healthcare facility is one of these amenities. It stopped the use of chloroquine in the treatment method of COVID-19 about two months back.

“There were being experiences of suspected more really serious side consequences than we very first thought,” Magnus Gisslen, a professor and main physician at Sahlgrenska College Healthcare facility an infection clinic, explained to the Gothenburg Submit on April 1, Newsweek described.

“We can’t rule out really serious side consequences, primarily from the heart, and it is a really hard-dosed drug. In addition, we have no strong proof that chloroquine has an influence on COVID-19,” Magnus Gisslen claimed.

No unique drugs are applied to handle COVID-19 but some men and women have advocated the use of the anti-malarial drugs chloroquine and hydroxychloroquine.

U.S. President Donald Trump has touted the use of hydroxychloroquine in individual and announced Sunday that the federal govt experienced stockpiled 29 million hydroxychloroquine capsules for the treatment method of COVID-19, Newsweek described.

The use of hydroxychloroquine to handle COVID-19 was authorised very last thirty day period by the U.S. Food stuff and Drug Administration, even though scientific scientific tests of the two anti-malarial drugs have yielded blended benefits.

For illustration, one research observed they give no supplemental profit to COVID-19 patients who are currently getting antiviral drugs, Newsweek described.

WebMD News from HealthDay


Copyright © 2013-2018 HealthDay. All rights reserved.